Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125535541 | 12553554 | 1 | I | 20160608 | 20160707 | 20160713 | 20160713 | EXP | FR-PFIZER INC-2016335173 | PFIZER | 72.00 | YR | F | Y | 0.00000 | 20160713 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125535541 | 12553554 | 1 | PS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 60 MG, SINGLE | U | 11856 | 60 | MG | |||||||
| 125535541 | 12553554 | 2 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 14 COURSES OF FOLFIRI AND BEVACIZUMAB | Y | 20571 | |||||||||
| 125535541 | 12553554 | 3 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 29 MG, SINGLE | Y | 20571 | 29 | MG | |||||||
| 125535541 | 12553554 | 4 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 14 COURSES OF FOLFIRI AND BEVACIZUMAB | U | 0 | |||||||||
| 125535541 | 12553554 | 5 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 550 MG, SINGLE | U | 0 | 550 | MG | |||||||
| 125535541 | 12553554 | 6 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 14 COURSES OF FOLFIRI AND BEVACIZUMAB | Y | 0 | |||||||||
| 125535541 | 12553554 | 7 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 80 MG, SINGLE | Y | 0 | 80 | MG | |||||||
| 125535541 | 12553554 | 8 | SS | ZOPHREN /00955302/ | ONDANSETRON | 1 | Intravenous bolus | 8 MG, SINGLE | U | 0 | 8 | MG | |||||||
| 125535541 | 12553554 | 9 | SS | ATROPINE. | ATROPINE | 1 | Intravenous bolus | 0.25 MG, SINGLE | U | 0 | .25 | MG | |||||||
| 125535541 | 12553554 | 10 | C | FLUOROURACIL. | FLUOROURACIL | 1 | 14 COURSES OF FOLFIRI AND BEVACIZUMAB | 0 | |||||||||||
| 125535541 | 12553554 | 11 | C | FLUOROURACIL. | FLUOROURACIL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125535541 | 12553554 | 1 | Premedication |
| 125535541 | 12553554 | 2 | Colon cancer metastatic |
| 125535541 | 12553554 | 4 | Colorectal cancer metastatic |
| 125535541 | 12553554 | 6 | Colon cancer metastatic |
| 125535541 | 12553554 | 8 | Premedication |
| 125535541 | 12553554 | 9 | Premedication |
| 125535541 | 12553554 | 10 | Colorectal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125535541 | 12553554 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125535541 | 12553554 | Cough | |
| 125535541 | 12553554 | Larynx irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125535541 | 12553554 | 1 | 20160608 | 0 | ||
| 125535541 | 12553554 | 3 | 20160608 | 20160608 | 0 | |
| 125535541 | 12553554 | 5 | 20160608 | 0 | ||
| 125535541 | 12553554 | 7 | 20160608 | 20160608 | 0 | |
| 125535541 | 12553554 | 8 | 20160608 | 0 | ||
| 125535541 | 12553554 | 9 | 20160608 | 0 | ||
| 125535541 | 12553554 | 11 | 20160608 | 0 |